Northwest Biotherapeutics | 8-K:重大事件
Northwest Biotherapeutics | DEF 14A:股东委托书决议
Northwest Biotherapeutics | PRE 14A:并购重组委托声明
Northwest Biotherapeutics | 10-Q:季度报表
Northwest Biotherapeutics | 8-K:重大事件
Northwest Biotherapeutics | 10-K/A:年度报表(修正版)
Northwest Biotherapeutics | 8-K:重大事件
Northwest Biotherapeutics | 8-K:重大事件
Northwest Biotherapeutics | 10-K:年度报表
Northwest Biotherapeutics | NT 10-K:其他
Northwest Biotherapeutics | 4:持股变动声明-董事 MALIK NAVID
Northwest Biotherapeutics | 8-K:重大事件
Northwest Biotherapeutics:2023财年三季报
Northwest Biotherapeutics | 10-Q:2023财年二季报
Northwest Biotherapeutics | 10-Q:2023财年一季报
Northwest Biotherapeutics | 4:持股变动声明-高管 BOSCH MARNIX L
Northwest Biotherapeutics | 4:持股变动声明-高管 BOYNTON ALTON L
Northwest Biotherapeutics | 8-K:重大事件
Northwest Biotherapeutics:2022财年年报
10-K | NORTHWEST BIOTHERAPEUTICS INC (0001072379) (Filer)
Northwest Biotherapeutics | 5:权益变更年度报表-高管 BOYNTON ALTON L
暂无数据